Systematic Review and Meta-Analysis of Metabolic Changes Linked to Sacubitril/Valsartan Therapy - Top-Institutions - MDSpire

Systematic Review and Meta-Analysis of Metabolic Changes Linked to Sacubitril/Valsartan Therapy

By
Amir Parsa Abhari
Parastesh Rezvanian
Ali Reza Rahmani
Mohammad Fakhrolmobasheri
Fouad Meraji Far
Negar Ostadsharif
Farzad Adelparvar
February 9, 2026
0 min

Bmc Cardiovascular Disorders

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

#1

Cleveland Clinic

Cleveland, OH
Key Differentiators
- Cardiology
- Heart Failure
- Metabolic Research
#2

Massachusetts General Hospital

Boston, MA
Key Differentiators
- Cardiology
- Endocrinology
- Clinical Pharmacology
#3

Johns Hopkins Hospital

Baltimore, MD
Key Differentiators
- Cardiology
- Nephrology
- Metabolic Disorders
#4

University of California, San Francisco (UCSF) Medical Center

San Francisco, CA
Key Differentiators
- Cardiology
- Endocrinology
- Clinical Research
#5

Brigham and Women's Hospital

Boston, MA
Key Differentiators
- Cardiology
- Metabolism
- Clinical Trials

Original Source(s)

Bmc Cardiovascular Disorders

Systematic Review and Meta-Analysis of Metabolic Changes Linked to Sacubitril/Valsartan Therapy

by Amir Parsa Abhari, Parastesh Rezvanian, Ali Reza Rahmani, Mohammad Fakhrolmobasheri, Fouad Meraji Far, Negar Ostadsharif, Farzad Adelparvar
February 9, 2026

Related Content

Conexiant

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

by Kathryn Wighton
May 21, 2026
2 min

Jama Network Open

Clinical Decision Support Systems and Blood Pressure Control—One Piece of a Larger Puzzle

by Deborah Onakomaiya, Valy Fontil
May 27, 2026

Jama Network Open

Clinical Decision Support System, Antihypertensive Treatment Intensification, and Blood Pressure Control: A